These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Long course metastasis in renal adenocarcinoma. Adrenal gland involvement]. de Nova Sánchez E; Prieto Chaparro L; Galán Llopis JA; Lloréns Martínez F; Fernández Puentes C; Menéndez López V; García López F Arch Esp Urol; 2000 May; 53(4):377-82. PubMed ID: 10900772 [TBL] [Abstract][Full Text] [Related]
27. [A case of renal cell carcinoma with solitary metastasis to the contralateral adrenal gland]. Arai G; Kamai T; Nagamoto A; Saito K; Hirokawa M Hinyokika Kiyo; 1997 Jan; 43(1):29-31. PubMed ID: 9046418 [TBL] [Abstract][Full Text] [Related]
28. Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience. Galanis E; Hersh EM; Stopeck AT; Gonzalez R; Burch P; Spier C; Akporiaye ET; Rinehart JJ; Edmonson J; Sobol RE; Forscher C; Sondak VK; Lewis BD; Unger EC; O'Driscoll M; Selk L; Rubin J J Clin Oncol; 1999 Oct; 17(10):3313-23. PubMed ID: 10506635 [TBL] [Abstract][Full Text] [Related]
29. Exophytic Tumor Growth After Incomplete Removal of Polypoid Malignant Melanoma of the Maxillary Gingiva: A Case Report and Review of the Literature. Taga T; Nonaka T; Manabe T; Bessho K J Oral Maxillofac Surg; 2016 Nov; 74(11):2328.e1-2328.e8. PubMed ID: 27566460 [TBL] [Abstract][Full Text] [Related]
30. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. Rosenberg SA; Yang JC; Topalian SL; Schwartzentruber DJ; Weber JS; Parkinson DR; Seipp CA; Einhorn JH; White DE JAMA; 1994 Mar 23-30; 271(12):907-13. PubMed ID: 8120958 [TBL] [Abstract][Full Text] [Related]
31. Mucosal Malignant Melanoma of Nasal Cavity Recurring a Year After Radiotherapy. Çomunoğlu C; Kuzey GM; Inançli M; Baba F; Özkayalar H Turk Patoloji Derg; 2017; 33(1):66-69. PubMed ID: 28044299 [TBL] [Abstract][Full Text] [Related]
32. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. Kuczyk M; Wegener G; Jonas U Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136 [TBL] [Abstract][Full Text] [Related]
33. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma]. Pluot M; Joundi A; Grosshans E Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764 [TBL] [Abstract][Full Text] [Related]
34. Primary malignant melanoma of the esophagus. Joob AW; Haines GK; Kies MS; Shields TW Ann Thorac Surg; 1995 Jul; 60(1):217-22. PubMed ID: 7598604 [TBL] [Abstract][Full Text] [Related]
35. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy. Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737 [TBL] [Abstract][Full Text] [Related]
36. A GRIA2 and PAX8-positive renal solitary fibrous tumor with NAB2-STAT6 gene fusion. Ichiyanagi O; Ito H; Takai S; Naito S; Kato T; Nagaoka A; Yamakawa M Diagn Pathol; 2015 Sep; 10():155. PubMed ID: 26337721 [TBL] [Abstract][Full Text] [Related]
37. [Late recurrence of malignant tumours 20 years after diagnosis and treatment]. Chodorowski Z; Sein Anand J; Jassem J; Kopacz A; Kruszewski W; Emerich J; Senkus-Konefka E Przegl Lek; 2007; 64(4-5):372-3. PubMed ID: 17724919 [TBL] [Abstract][Full Text] [Related]
38. [Long-term survival of a patient with melanoma with late recurrence of pulmonary metastasis treated by repeat surgery]. Ferri RM; Thomas P; Tramier H; Guidicelli R; Kleisbauer JP Rev Mal Respir; 1999 Apr; 16(2):204-5. PubMed ID: 10339764 [TBL] [Abstract][Full Text] [Related]
39. Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma. Margolin K; Atkins M; Sparano J; Sosman J; Weiss G; Lotze M; Doroshow J; Mier J; O'Boyle K; Fisher R; Campbell E; Rubin J; Federighi D; Bursten S Clin Cancer Res; 1997 Apr; 3(4):565-72. PubMed ID: 9815721 [TBL] [Abstract][Full Text] [Related]
40. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial. Arai S; Meagher R; Swearingen M; Myint H; Rich E; Martinson J; Klingemann H Cytotherapy; 2008; 10(6):625-32. PubMed ID: 18836917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]